Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,Inverse variance weighted,41,0.97 [0.95-0.99],0.00389729269768759,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,L12_SKIN_SUBCUTAN,Inverse variance weighted,22,1.03 [1.01-1.05],0.00543967818127287,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_CORATHER,Inverse variance weighted,41,0.98 [0.96-0.99],0.0101719954194277,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,J10_PLEURA,Inverse variance weighted,41,0.97 [0.95-1],0.0289435145942236,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERANAEMIA,Inverse variance weighted,22,1.03 [1-1.06],0.0302519194292408,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_MUSCULOSKELETAL,Inverse variance weighted,22,1.01 [1-1.03],0.0362706164936741,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,41,0.98 [0.96-1],0.0521012464731135,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_IHD,Inverse variance weighted,41,0.99 [0.97-1],0.0607940368931681,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Inverse variance weighted,41,0.97 [0.94-1],0.0700326915860603,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOPOROSIS,Inverse variance weighted,41,0.97 [0.93-1.01],0.100650736347053,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_HYPOTE,Inverse variance weighted,41,1.04 [0.99-1.08],0.113974585332467,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,ALCOHOLMENTAL,Inverse variance weighted,22,0.96 [0.9-1.01],0.114972030249147,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,K11_GIDISEASES,Inverse variance weighted,22,0.99 [0.97-1],0.115325262297292,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,Inverse variance weighted,22,0.93 [0.85-1.02],0.116572324513914,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,COPD_HOSPITAL_MAIN,Inverse variance weighted,22,1.03 [0.99-1.06],0.128637739301123,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,41,1.01 [1-1.03],0.147974500513244,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOCHONDRO,Inverse variance weighted,41,0.98 [0.96-1.01],0.1482408937402,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_PAROXTAC,Inverse variance weighted,41,0.98 [0.94-1.01],0.150511930478917,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_AF,Inverse variance weighted,41,0.99 [0.97-1.01],0.155933641268436,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOKALAEMIA,Inverse variance weighted,41,1.04 [0.98-1.1],0.17301715983279,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,G6_MS,Inverse variance weighted,41,1.04 [0.98-1.11],0.177377005533609,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,J10_PLEUREFFUSION,Inverse variance weighted,41,0.97 [0.93-1.02],0.200595035585312,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Inverse variance weighted,41,0.99 [0.97-1.01],0.216250457892135,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,41,1.01 [1-1.02],0.21692892377375,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,41,0.99 [0.97-1.01],0.218492512506479,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Inverse variance weighted,41,1.04 [0.97-1.11],0.241421246969191,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,41,1.02 [0.99-1.04],0.245704229892329,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_PULMOTHHD,Inverse variance weighted,22,1.05 [0.96-1.15],0.267794367176229,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,41,1.01 [0.99-1.04],0.314380256385929,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,J10_RESPDISOTH,Inverse variance weighted,22,1.02 [0.98-1.05],0.328075332739869,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,Inverse variance weighted,41,0.99 [0.98-1.01],0.367370389058336,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,41,0.98 [0.93-1.03],0.369965702404174,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_OBESITYNAS,Inverse variance weighted,41,1.01 [0.98-1.04],0.391116265576666,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,41,1.01 [0.99-1.02],0.393961604050199,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS,Inverse variance weighted,41,1.01 [0.99-1.02],0.408674032876807,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,41,0.99 [0.97-1.01],0.420107404393572,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,22,1.01 [0.99-1.04],0.427236993447956,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_OTHILLHEART,Inverse variance weighted,41,0.97 [0.9-1.05],0.436638314533543,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,AB1_INFECT_PARASIT,Inverse variance weighted,22,1.01 [0.99-1.03],0.461411547908864,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_OTH,Inverse variance weighted,41,1.01 [0.98-1.04],0.46694657805756,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_BLOOD_IMMUN,Inverse variance weighted,22,1.01 [0.99-1.03],0.470069145360461,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_EXPLICIT,Inverse variance weighted,22,1.02 [0.97-1.06],0.478741311770661,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,41,1.01 [0.99-1.02],0.492950786283267,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_HYPTENSPUL,Inverse variance weighted,41,0.94 [0.77-1.14],0.516182453387695,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,J10_INTERSTITIUM,Inverse variance weighted,22,1.02 [0.95-1.1],0.51658404250093,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,41,1.01 [0.99-1.02],0.516768260609043,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,NEURODEGOTH,Inverse variance weighted,41,0.99 [0.96-1.02],0.529225690767212,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACT_INOTHER,Inverse variance weighted,41,1.07 [0.87-1.3],0.533882384943727,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,LUNG_CANCER_MESOT,Inverse variance weighted,22,0.98 [0.91-1.05],0.536906960120068,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Inverse variance weighted,41,1.01 [0.98-1.05],0.559014506319854,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,COPD_LATER,Inverse variance weighted,41,0.99 [0.96-1.02],0.560637180384109,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,41,1 [0.99-1.01],0.566050889148432,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Inverse variance weighted,22,1.01 [0.98-1.04],0.604670528456603,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,AB1_BACT_BIR_OTHER_INF_AGENTS,Inverse variance weighted,41,1.01 [0.96-1.07],0.614453477157676,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Inverse variance weighted,41,1.01 [0.98-1.04],0.614779952347053,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,Inverse variance weighted,22,1.02 [0.95-1.09],0.633487935324204,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,COPD_EARLY,Inverse variance weighted,41,1.01 [0.97-1.04],0.649673107894063,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_PAD,Inverse variance weighted,22,0.99 [0.94-1.04],0.651122100433655,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,Inverse variance weighted,41,0.98 [0.89-1.08],0.651507011817479,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,AB1_STREPTSTAPHYCOCC_INOTHER,Inverse variance weighted,41,1.05 [0.83-1.34],0.669824090987689,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_OTHPER,Inverse variance weighted,41,0.99 [0.93-1.05],0.692652647366029,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Inverse variance weighted,41,0.99 [0.95-1.03],0.69276808877914,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Inverse variance weighted,41,0.99 [0.95-1.04],0.704711503334951,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,G6_NEURO,Inverse variance weighted,22,1 [0.98-1.01],0.709540494470246,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,N14_GENITOURINARY,Inverse variance weighted,22,1 [0.99-1.02],0.710989693526609,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Inverse variance weighted,41,1.01 [0.95-1.08],0.727882900555612,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,J10_RESPIRATORY,Inverse variance weighted,22,1 [0.98-1.02],0.73594901997719,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,41,1 [0.99-1.02],0.756173570270519,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,41,1 [0.98-1.01],0.76803283622821,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Inverse variance weighted,41,1 [0.98-1.02],0.780059446351312,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Inverse variance weighted,22,1 [0.98-1.03],0.789153125283237,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_INCLAVO,Inverse variance weighted,41,1 [0.99-1.02],0.789848179936705,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,Inverse variance weighted,41,1.01 [0.92-1.11],0.807347418848261,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Inverse variance weighted,41,0.98 [0.86-1.12],0.809775080972582,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,41,1 [0.98-1.01],0.818158162580767,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Inverse variance weighted,22,1 [0.98-1.02],0.822717102385185,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_OBESITY,Inverse variance weighted,41,1 [0.98-1.02],0.85156209822394,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,Inverse variance weighted,41,0.98 [0.77-1.24],0.853199759015936,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,ASTHMA_NAS,Inverse variance weighted,41,1 [0.98-1.02],0.886183087966284,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,41,1 [0.96-1.04],0.941253997257712,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,41,1 [0.98-1.02],0.967985240534965,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_BACT_IMPL,Inverse variance weighted,22,1 [0.97-1.04],0.985110081649502,cis
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,14,0.71 [0.51-0.97],0.0341622237139505,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Inverse variance weighted,14,0.61 [0.38-0.98],0.0415788482624049,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,14,0.7 [0.48-1],0.0530144038339053,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,14,1.18 [0.99-1.41],0.0635522522319969,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,14,0.85 [0.71-1.01],0.0677871391432686,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,14,0.9 [0.81-1.01],0.0700928548773356,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,14,1.15 [0.98-1.35],0.0836558890354043,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_AF,Inverse variance weighted,14,1.18 [0.97-1.42],0.0934584121410719,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,14,1.14 [0.97-1.34],0.10251317934714,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,COPD_EARLY,Inverse variance weighted,14,0.77 [0.56-1.06],0.115177188643111,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_HYPOTE,Inverse variance weighted,14,1.31 [0.93-1.83],0.117674996943652,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,Inverse variance weighted,14,3.99 [0.67-23.79],0.128424983011319,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,ASTHMA_NAS,Inverse variance weighted,14,0.87 [0.72-1.04],0.130444548433536,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Inverse variance weighted,14,1.14 [0.96-1.34],0.136823225486867,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,14,1.1 [0.97-1.26],0.142904081056768,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,14,0.9 [0.78-1.04],0.161975292798286,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,14,0.89 [0.76-1.05],0.168245122209989,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Inverse variance weighted,14,0.86 [0.68-1.08],0.198698813684683,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,J10_PLEURA,Inverse variance weighted,14,0.85 [0.66-1.09],0.20631093647667,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,AB1_STREPTSTAPHYCOCC_INOTHER,Inverse variance weighted,14,0.26 [0.03-2.22],0.217146626615432,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Inverse variance weighted,14,1.13 [0.93-1.37],0.217183924874241,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Inverse variance weighted,14,1.22 [0.88-1.69],0.235876392420258,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Inverse variance weighted,14,1.19 [0.86-1.66],0.293967307274717,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Inverse variance weighted,14,1.71 [0.62-4.67],0.299019641026433,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS,Inverse variance weighted,14,1.07 [0.94-1.21],0.321393464937714,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,14,1.04 [0.96-1.13],0.36899824662501,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Inverse variance weighted,14,0.87 [0.64-1.19],0.381904154924002,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOKALAEMIA,Inverse variance weighted,14,1.19 [0.81-1.75],0.383113712497591,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,Inverse variance weighted,14,0.93 [0.79-1.1],0.414230855213139,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_OTH,Inverse variance weighted,14,1.07 [0.9-1.27],0.42115116054489,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,14,0.94 [0.81-1.09],0.441204667359396,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,Inverse variance weighted,14,0.96 [0.87-1.06],0.44890478642053,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_OTHPER,Inverse variance weighted,14,1.19 [0.71-1.99],0.515043798913556,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,14,0.91 [0.67-1.22],0.517817276997605,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,J10_PLEUREFFUSION,Inverse variance weighted,14,0.89 [0.61-1.29],0.525172983862822,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACT_INOTHER,Inverse variance weighted,14,1.48 [0.38-5.84],0.573712642587933,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOPOROSIS,Inverse variance weighted,14,0.92 [0.67-1.27],0.613794934487856,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,NEURODEGOTH,Inverse variance weighted,14,0.93 [0.72-1.22],0.614942442479463,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOCHONDRO,Inverse variance weighted,14,1.04 [0.88-1.23],0.615484208611979,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,Inverse variance weighted,14,1.18 [0.6-2.33],0.62404155540749,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,G6_MS,Inverse variance weighted,14,1.13 [0.67-1.93],0.645237465949832,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,COPD_LATER,Inverse variance weighted,14,0.93 [0.67-1.29],0.661980145580757,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,Inverse variance weighted,14,0.89 [0.5-1.59],0.693435301464696,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,14,1.04 [0.85-1.28],0.696561183676051,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Inverse variance weighted,14,0.96 [0.76-1.21],0.737244886024259,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Inverse variance weighted,14,1.09 [0.65-1.84],0.738267944211025,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_OBESITY,Inverse variance weighted,14,0.97 [0.78-1.19],0.743704179067385,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_PAROXTAC,Inverse variance weighted,14,0.96 [0.76-1.22],0.756342409867857,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,AB1_BACT_BIR_OTHER_INF_AGENTS,Inverse variance weighted,14,1.05 [0.67-1.64],0.822356439483038,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_HYPTENSPUL,Inverse variance weighted,14,1.18 [0.28-5.01],0.82530104274832,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_OTHILLHEART,Inverse variance weighted,14,1.04 [0.59-1.84],0.884022491758128,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,14,0.99 [0.85-1.15],0.888500533994506,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_OBESITYNAS,Inverse variance weighted,14,1.01 [0.78-1.33],0.917162470727316,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_INCLAVO,Inverse variance weighted,14,0.99 [0.88-1.13],0.923137735748601,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_IHD,Inverse variance weighted,14,1.01 [0.87-1.17],0.930998356637443,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,I9_CORATHER,Inverse variance weighted,14,0.99 [0.83-1.19],0.941107092225848,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,14,1 [0.92-1.08],0.948015505135818,trans
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,14,1 [0.87-1.15],0.96930463063949,trans
